Efficacy of single-agent therapy for the treatment of acute pelvic inflammatory disease with ciprofloxacin
- 1 November 1989
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Medicine
- Vol. 87 (5) , S142-S147
- https://doi.org/10.1016/0002-9343(89)90045-4
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Microbiological and histopathological findings in acute pelvic inflammatory diseaseBJOG: An International Journal of Obstetrics and Gynaecology, 1987
- Pelvic Inflammatory Disease and Infertility in WomenInfectious Disease Clinics of North America, 1987
- Pharmacokinetics of ciprofloxacin in healthy volunteers after oral and intravenous administrationEuropean Journal of Clinical Microbiology & Infectious Diseases, 1986
- The activity of ciprofloxacin and other 4-quinolones againstChlamydia trachomatis andMycoplasmas in vitroEuropean Journal of Clinical Microbiology & Infectious Diseases, 1984
- Antibacterial activities of ciprofloxacin, norfloxacin, oxolinic acid, cinoxacin, and nalidixic acidAntimicrobial Agents and Chemotherapy, 1984
- Ciprofloxacin, a quinolone carboxylic acid compound active against aerobic and anaerobic bacteriaAntimicrobial Agents and Chemotherapy, 1984
- Failure of β-Lactam Antibiotics to Eradicate Chlamydia trachomatis in the Endometrium Despite Apparent Clinical Cure of Acute SalpingitisJAMA, 1983
- Economic consequences of pelvic inflammatory disease in the United StatesAmerican Journal of Obstetrics and Gynecology, 1980
- Microbiology and pathogenesis of acute salpingitis as determined by laparoscopy: What is the appropriate site to sample?American Journal of Obstetrics and Gynecology, 1980
- Polymicrobial Etiology of Acute Pelvic Inflammatory DiseaseNew England Journal of Medicine, 1975